References
- Berger F, Isaacson P G, Piris M A, Harris N L, Müller-Hermelink H K, Nathwani B N, . Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Mature B-cell neoplasms. Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours, E S Jaffe, N L Harris, H Stein, J W Vardiman, et al. IARC Press, Lyon 2001
- Carmichael A, Sissons J GP. The Immune Response to HIV. Medicine 2001; 29: 4–8
- Guidelines for the use of Antiretroviral agents in HIV-1-infected adults and adolscents, DHHS guidelines. http://www.aidsinfo.nih.gov/guidelines/adult/AA_032304.pdf.
- Cuada R, Lucia M B, Marasca G, Rutella S, Petrucci M T, La Verde G, et al. Beneficail effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy. Eur J Haematol 1999; 63: 134–135
- von Keyserlingk H, Baur R, Stein H, Hoeffken G, Thiel E. Multiple myeloma in a patient at risk for AIDS. Cancer Detect Prev 1990; 14: 403–404
- Fiorino A S, Atae B. Paraproteinemia, plasmacytoma, myeloma and HIV infection. Leukemia 1997; 11: 2150–2156
- Jin D K, Nowakowski M, Kramer M, Essex D W. Hyperviscosity syndrome secondary to a myeloma-assocaited IgG(I)-kappa paraprotein strongly reactive against the HIV-1 p2 gag antigen. Am J Haematol 2000; 64: 210–213
- Nasta S D, Carrum G M, Shahab I, Hanania N A, Udden M M. Regression of a Plasmablastic Lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma 2002; 43: 423–426